SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: Their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels

Biochemical Journal

Volumn 376, Issue 1, 2003, Pages 199-207

  Giuriato, Sylvie ^a,b,f   Pesesse, Xavier ^b   Bodin, Stéphane ^a   Sasaki, Takehiko ^c,d   Viala, Cécile ^a   Marion, Evelyne ^b   Penninger, Joseph ^e   Schurmans, Stéphane ^b   Erneux, Christophe ^b   Payrastre, Bernard ^a  

^a CHU PURPAN   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c AKITA UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Haematopoietic cell; Platelet; PtdIns(3,4,5)P3; Src homology domain 2 (SH2) containing inositol 5 phosphatase

Indexed keywords

BLOOD; CELLS; COLLAGEN; ENZYMES; LIPIDS; PHOSPHATES; SIGNALING; TUMORS;

BLOOD PLATELETS; LYMPHOMA;

BIOCHEMISTRY;

COLLAGEN; LIPID; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN; SHIP1 PROTEIN; SHIP2 PROTEIN; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; DEPHOSPHORYLATION; GENE DELETION; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SRC HOMOLOGY DOMAIN; THROMBOCYTE;

EID: 0345688084     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20030581     Document Type: Article

References (47)

1. Erneux, C., Govaerts, C., Communi, D. and Pesesse, X. (1998) The diversity and possible functions of the inositol polyphosphate 5-phosphatases. Biochim. Biophys. Acta 1436, 185-199
2. Drayer, A. L., Pesesse, X., De Smedt, F., Woscholski, R., Parker, P. and Erneux, C. (1996) Cloning and expression of a human placenta inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Biochem. Biophys. Res. Commun. 225, 243-249
3. Pesesse, X., Deleu, S., De Smedt, F., Drayer, L. and Erneux, C. (1997) Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem. Biophys. Res, Commun. 239, 697-700
4. Rohrschneider, L. R., Fuller, J. F., Wolf, I., Liu, Y. and Lucas, D. M. (2000) Structure, function, and biology of SHIP proteins. Genes Dev. 14, 505-520
5. Liu, Q., Oliveira-Dos-Santos, A. J., Mariathasan, S., Bouchard, D., Jones, J., Sarao, R., Kozieradzki, I., Ohashi, P. S., Penninger, J. M. and Dumont, D. J. (1998) The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J. Exp. Med. 188, 1333-1342
6. Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J. and Penninger, J. M. (1999) SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev. 13, 786-791
7. Huber, M., Helgason, C. D., Scheid, M. P., Duronio, V., Humphries, R. K. and Krystal, G. (1998) Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells. EMBO J. 17, 7311-7319
8. Valderrama-Carvajal, H., Cocolakis, E., Lacerte, A., Lee, E. H., Krystal, G., Ali, S. and Lebrun, J. J. (2002) Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat. Cell Biol. 4, 963-969
9. Helgason, C. D., Damen, J. E., Rosten, P., Grewal, R., Sorensen, P., Chappel, S. M., Borowski, A., Jirik, F., Krystal, G. and Humphries, R. K. (1998) Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12, 1610-1620
10. Huber, M., Helgason, C. D., Damen, J. E., Scheid, M., Duronio, V., Liu, L., Ware, M. D., Humphries, R. K. and Krystal, G. (1999) The role of SHIP in growth factor induced signalling. Prog. Biophys. Mol. Biol. 71, 423-434
11. Luo, J. M., Yoshida, H., Komura, S., Ohishi, N., Pan, L., Shigeno, K., Hanamura, I., Miura, K., Iida, S., Ueda, R. et al. (2003) Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia. Leukemia 17, 1-8
12. Sattler, M., Verma, S., Byrne, C. H., Shrikhande, G., Winkler, T., Algate, P. A., Rohrschneider, L. R. and Griffin, J. D. (1999) BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis. Mol. Cell. Biol. 19, 7473-7480
13. Rey-Ladino, J. A., Huber, M., Liu, L., Damen, J. E., Krystal, G. and Takei, F. (1999) The SH2-containtng inositol-5′-phosphatase enhances LFA-1-mediated cell adhesion and defines two signaling pathways for LFA-1 activation. J. Immunol. 162, 5792-5799
14. Mancini, A., Koch, A., Wilms, R. and Tamura, T. (2002) The SH2-containing inositol 5-phosphatase (SHIP)-1 is implicated in the control of cell-cell junction and induces dissociation and dispersion of MDCK cells. Oncogene 21, 1477-1484
15. Wang, J. W., Howson, J. M., Ghansah, T., Desponts, C., Ninos, J. M., May, S. L., Nguyen, K. H., Toyama-Sorimachi, N. and Kerr, W. G. (2002) Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science 295, 2094-2097
16. Takeshita, S., Namba, N., Zhao, J. J., Jiang, Y., Genant, H. K., Silva, M. J., Brodt, M. D., Helgason, C. D., Kalesnikoff, J., Rauh, M. J. et al. (2002) SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat. Med. (Tokyo) 8, 943-949
17. Muraille, E., Pesesse, X., Kuntz, C. and Erneux, C. (1999) Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells. Biochem. J. 342, 697-705
18. Habib, T., Hejna, J. A., Moses, R. E. and Decker, S. J. (1998) Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein. J. Biol. Chem. 273, 18605-18609
19. Taylor, V., Wong, M., Brandts, C., Reilly, L., Dean, N. M., Cowsert, L. M., Moodie, S. and Stokoe, D. (2000) 5′ Phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol. Cell. Biol. 20, 6860-6871
20. Giuriato, S., Blero, D., Robaye, B., Bruyns, C., Payrastre, B. and Erneux, C. (2002) SHIP2 overexpression strongly reduces the proliferation rate of K562 erythroleukemia cell line. Biochem. Biophys. Res. Commun. 296, 106-110
21. Prasad, N., Topping, R. S. and Decker, S. J. (2001) SH2-containing inositol 5′-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading. Mol. Cell. Biol, 21, 1416-1428
22. Dyson, J. M., O'Malley, C. J., Becanovic, J., Munday, A. D., Berndt, M. C., Coghill, I. D., Nandurkar, H. H., Ooms, L. M. and Mitchell, C. A. (2001) The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J. Cell Biol, 155, 1065-1079
23. Clement, S., Krause, U., Desmedt, F., Tanti, J. F., Behrends, J., Pesesse, X., Sasaki, T., Penninger, J., Doherty, M., Malaisse, W. et al. (2001) The lipid phosphatase SHIP2 controls insulin sensitivity. Nature (London) 409, 92-97
24. Giuriato, S., Payrastre, B., Drayer, A. L., Plantavid, M., Woscholski, R., Parker, P., Erneux, C. and Chap, H. (1997) Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets. J. Biol. Chem. 272, 26857-26863
25. Giuriato, S., Bodin, S., Erneux, C., Woscholski, R., Plantavid, M., Chap, H. and Payrastre, B. (2000) pp60c-src associates with the SH2-containing inositol-5-phosphatase SHIP1 and is involved in its tyrosine phosphorylation downstream of αIIbβ3 integrin in human platelets. Biochem. J. 348, 107-112
26. Trumel, C., Payrastre, B., Plantavid, M., Hechler, B., Viala, C., Presek, P., Martinson, E. A., Cazenave, J. P., Chap, H. and Cachet, C. (1999) A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood 94, 4156-4165
27. 2+ entry via btk in platelets and megakaryocytes without increasing phospholipase C activity. EMBO J. 19, 2793-2802
28. Bruyns, C., Pesesse, X., Moreau, C., Blero, D. and Erneux, C. (1999) The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes. Biol. Chem. 380, 969-974
29. Wisniewski, D., Strife, A., Swendeman, S., Erdjument-Bromage, H., Geromanos, S., Kavanaugh, W. M., Tempst, P. and Clarkson, B. (1999) A novel SH2-containing Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood 93, 2707-2720
30. Muraille, E., Bruhns, P., Pesesse, X., Daeron, M. and Erneux, C. (2000) The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fcγ RIIB in B cells under negative signaling. Immunol. Lett. 72, 7-15
31. Bruhns, P., Vely, F., Malbec, O., Fridman, W. H., Vivier, E. and Daeron, M. (2000) Molecular basis ot the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by fcγ RIIB. J. Biol. Chem. 275, 37357-37364
32. Brauweiler, A., Tamir, I., Marschner, S., Helgason, C. D. and Cambier, J. C. (2001) Partially distinct molecular mechanisms mediate inhibitory FcγRIIB signaling in resting and activated B cells. J. Immunol. 167, 204-211
33. 2 is required for PKB phosphorylation at Ser-473: studies using cells from SH2-containing inositol-5-phosphatase knockout mice. J. Biol. Chem. 277, 9027-9035
34. Cazenave, J. P., Hemmendinger, S., Beretz, A., Sutter-Bay, A. and Launay, J. (1983) Platelet aggregation: a tool for clinical investigation and pharmacological study. Methodology. Ann. Biol. Clin. (Paris) 41, 167-179
35. Bligh, E. G. and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917
36. Gratacap, M. P., Payrastre, B., Viala, C., Mauco, G., Plantavid, M. and Chap, H. (1998) Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-γ2 is an early key event in FcγRIIA-mediated activation of human platelets. J. Biol. Chem. 273, 24314-24321
37. Pesesse, X., Moreau, C., Drayer, A. L., Woscholski, R., Parker, P. and Erneux, C. (1998) The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosptiate 5-phosphatase activity. FEBS Lett. 437, 301-303
38. Pesesse, X., Dewaste, V., De Smedt, F., Laffargue, M., Giuriato, S., Moreau, C., Payrastre, B. and Erneux, C. (2001) The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells. J. Biol. Chem. 276, 28348-28355
39. Payrastre, B., Missy, K., Giuriato, S., Bodin, S., Plantavid, M. and Gratacap, M. (2001) Phosphoinositides: key players in cell signalling, in time and space. Cell. Signal. 13, 377-387
40. Damen, J. E., Liu, L., Ware, M. D., Ermolaeva, M., Majerus, P. W. and Krystal, G. (1998) Multiple forms of the SH2-containing inositol phosphatase, SHIP, are generated by C-terminal truncation. Blood 92, 1199-1205
41. Horn, S., Meyer, J., Heukeshoven, J., Fehse, B, Schulze, C., Li, S., Frey, J., Poll, S., Stocking, C. and Jucker, M. (2001) The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyltruncated forms of SHIP are generated by proteolytic cleavage in vitro. Leukemia 15, 112-120
42. Dyson, J. M., Munday, A. D., Kong, A. M., Huysmans, R. D., Matzaris, M., Layton, M. J., Nandurkar, H. H., Berndt, M. C. and Mitchell, C. A. (2003) SHIP-2 forms a tetrameric complex with filamin, actin, and GPIb-IX-V: localization of SHIP-2 to the activated platelet actin cytoskeleton. Blood 102, 940-948
43. Osborne, M. A., Zenner, G., Lubinus, M., Zhang, X., Songyang, Z., Cantley, L. C., Majerus, P., Burn, P. and Kochan, J. P. (1996) The inositol 5′-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation. J. Biol. Chem. 271, 29271-29278
44. Tridandapani, S., Pradhan, M., LaDine, J. R., Garber, S., Anderson, C. L. and Coggeshall, K. M. (1999) Protein interactions of Src homology 2 (SH2) domain-containing inositol phosphatase (SHIP): association with Shc displaces SHIP from FcγRIIb in B cells. J. Immunol. 162, 1408-1414
45. Hinchliffe, K. A., Giudici, M. L., Letcher, A. J. and Irvine, R. F. (2002) Type IIα phosphatidylinositol phosphate kinase associates with the plasma membrane via interaction with type I isoforms. Biochem. J. 363, 563-570
46. Jackson, S. P., Schoenwaelder, S. M., Matzaris, M., Brown, S. and Mitchell, C. A. (1995) Phosphatidylinositol 3,4,5-trisphosphate is a substrate for the 75 kDa inositol polyphosphate 5-phosphatase and a novel 5-phosphatase which forms a complex with the p85/p110 form of phosphoinositide 3-kinase. EMBO J. 14, 4490-4500
47. Zhang, J., Banfic, H., Straforini, F., Tosi, L., Volinia, S. and Rittenhouse, S. E. (1998) A type II phosphoinositide 3-kinase is stimulated via activated integrin in platelets. A source of phosphatidylinositol 3-phosphate. J. Biol. Chem. 273, 14081-14084